Literature DB >> 11430565

The diurnal rhythm of adrenocorticotropic hormone secretion in the assessment of the adequacy of replacement therapy in primary chronic adrenal failure.

V V Fadeev1, E P Gitel, G A Mel'nichenko.   

Abstract

Utilization of the daily rhythm of ACTH secretion was assessed as a measure of the adequacy of replacement therapy in primary chronic adrenal failure (PCAF: Addison's disease) with glucocorticoids (GC) by assaying plasma ACTH by radioimmunoassay every 4 h for one day in three groups of patients. Patients of group 1 had PCAF (n = 14) and received replacement therapy consisting of prednisolone (5 mg at 09:00 and 2.5 mg at 14:00) and group 2 patients received dexamethasone (0.5 mg at 23:00) in combination with prednisolone (2.5 mg at 14:00). All patients with PCAF also received 0.005-0.01 mg/day of 9alpha-fluorocortisol. The control group consisted of 14 healthy volunteers. Both types of replacement therapy resulted in high levels of variability in ACTH levels as compared with that in normal subjects. The areas under the curve (AUC) of the ACTH concentration over one day were not significantly different between groups 1 and 2 or between group 2 and controls. The AUC of ACTH in group 1 was significantly larger than that in controls. The mean ACTH concentration in group 1 at 07:00 and 11:00 was significantly greater than those in the other two groups. The daily rhythm of ACTH was generally closer to normal in patients given dexamethasone. Since our own clinical experience shows that at least two thirds of patients are initially given dexamethasone and that this had to be withdrawn because of the development of overdosage syndrome (weight gain, increased appetite, insomnia), it appears that there is a lack of concordance between the clinical data and the daily rhythm of ACTH secretion. When assessing the adequacy of replacement therapy in PCAF, it is important to note that the appearance of a normal rhythm of ACTH secretion over one day does not exclude the possibility of GC overdosage, with the effect that interpretation of the results of this type of measurement must take the clinical picture into account.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430565     DOI: 10.1023/a:1010318130933

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  10 in total

1.  Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy.

Authors:  R S Scott; R A Donald; E A Espiner
Journal:  Clin Endocrinol (Oxf)       Date:  1978-12       Impact factor: 3.478

2.  The comparative effect of 6 alpha-fluoroprednisolone, 6 alpha-methylprednisolone, and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease.

Authors:  Z Laron; A Pertzelan
Journal:  J Pediatr       Date:  1968-11       Impact factor: 4.406

Review 3.  [Therapy of adrenal cortex insufficiency].

Authors:  S Diederich; V Bähr; W Oelkers
Journal:  Dtsch Med Wochenschr       Date:  1994-04-22       Impact factor: 0.628

Review 4.  Addison's disease. How to improve patients' quality of life.

Authors:  S S Stoffer
Journal:  Postgrad Med       Date:  1993-03       Impact factor: 3.840

5.  Adrenal insufficiency.

Authors:  D N Orth
Journal:  Curr Ther Endocrinol Metab       Date:  1994

6.  Diurnal rhythm and disappearance half-time of endogenous plasma immunoreactive beta-MSH (LPH) and ACTH in man.

Authors:  K Tanaka; W E Nicholson; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

7.  Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states.

Authors:  W M Burch
Journal:  JAMA       Date:  1982-04-09       Impact factor: 56.272

8.  Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.

Authors:  G A Wittert; J H Livesey; C Florkowski; H K Or; R A Donald; E A Espiner
Journal:  J Clin Endocrinol Metab       Date:  1993-01       Impact factor: 5.958

9.  Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement.

Authors:  C M Feek; J G Ratcliffe; J Seth; C E Gray; A D Toft; W J Irvine
Journal:  Clin Endocrinol (Oxf)       Date:  1981-05       Impact factor: 3.478

10.  The pituitary gland in untreated Addison's disease. A histologic and immunocytologic study of 18 adenohypophyses.

Authors:  B W Scheithauer; K Kovacs; R V Randall
Journal:  Arch Pathol Lab Med       Date:  1983-09       Impact factor: 5.534

  10 in total
  3 in total

1.  Impact of Adiposity and Fat Distribution on the Dynamics of Adrenocorticotropin and Cortisol Rhythms.

Authors:  Ferdinand Roelfsema; Alberto M Pereira; Johannes D Veldhuis
Journal:  Curr Obes Rep       Date:  2014-12

2.  Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index.

Authors:  Johannes D Veldhuis; Ferdinand Roelfsema; Ali Iranmanesh; Bernard J Carroll; Daniel M Keenan; Steven M Pincus
Journal:  J Clin Endocrinol Metab       Date:  2009-09-15       Impact factor: 5.958

Review 3.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.